Your browser doesn't support javascript.
loading
Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation.
Cuartero, Sergi; Weiss, Felix D; Dharmalingam, Gopuraja; Guo, Ya; Ing-Simmons, Elizabeth; Masella, Silvia; Robles-Rebollo, Irene; Xiao, Xiaolin; Wang, Yi-Fang; Barozzi, Iros; Djeghloul, Dounia; Amano, Mariane T; Niskanen, Henri; Petretto, Enrico; Dowell, Robin D; Tachibana, Kikuë; Kaikkonen, Minna U; Nasmyth, Kim A; Lenhard, Boris; Natoli, Gioacchino; Fisher, Amanda G; Merkenschlager, Matthias.
Afiliação
  • Cuartero S; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Weiss FD; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Dharmalingam G; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Guo Y; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Ing-Simmons E; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Masella S; Computational Regulatory Genomics Group, Integrative Biology Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Robles-Rebollo I; Max Planck Institute for Molecular Biomedicine, Muenster, Germany.
  • Xiao X; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
  • Wang YF; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Barozzi I; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Djeghloul D; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Amano MT; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
  • Niskanen H; Department of Surgery and Cancer, Department of Medicine, Imperial College London, London, UK.
  • Petretto E; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Dowell RD; Lymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Tachibana K; Hospital Sírio-Libanês, Sao Paulo, Brazil.
  • Kaikkonen MU; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Nasmyth KA; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Lenhard B; Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, Singapore.
  • Natoli G; BioFrontiers Institute and Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO, USA.
  • Fisher AG; Department of Biochemistry, University of Oxford, Oxford, UK.
  • Merkenschlager M; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter, Vienna, Austria.
Nat Immunol ; 19(9): 932-941, 2018 09.
Article em En | MEDLINE | ID: mdl-30127433
ABSTRACT
Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression. Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and progenitor cells (HPSCs), cohesin mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli. These findings uncover an unexpected dependence of inducible gene expression on cohesin, link cohesin with myeloid differentiation, and may help explain the prevalence of cohesin mutations in human acute myeloid leukemia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Células-Tronco Hematopoéticas / Proteínas Nucleares / Proteínas Cromossômicas não Histona / Leucemia Mieloide Aguda / Diferenciação Celular / Proteínas de Ciclo Celular / Autorrenovação Celular / Macrófagos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Células-Tronco Hematopoéticas / Proteínas Nucleares / Proteínas Cromossômicas não Histona / Leucemia Mieloide Aguda / Diferenciação Celular / Proteínas de Ciclo Celular / Autorrenovação Celular / Macrófagos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido